Tisotumab vedotin Recruiting Phase 3 Trials for Cervical Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04697628Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer